Heart failure remains the leading cause of death worldwide, and is a burgeoning problem in
public health due to the limited capacity of postnatal hearts to self-renew. The …

Acute myocardial infarction leads to irreversible loss of cardiac myocytes, thereby
diminishing the pump function of the heart. As a result, the strenuous workload imposed on …

The common prevalence of heart failure and limitations in its treatment are leading cause of
attention and interest towards the induction of cardiac regeneration with novel approaches …

Myocardial infarction–induced heart failure is a prevailing cause of death in the United
States and most developed countries. The cardiac tissue has extremely limited regenerative …

Heart failure is the number one killer worldwide with~ 50% of patients dying within 5 years of
prognosis. The discovery of stem cells, which are capable of repairing the damaged portion …

Heart failure is a leading cause of death worldwide. Current therapies only delay
progression of the cardiac disease or replace the diseased heart with cardiac …

Heart failure emerges with a net loss of viable cardiomyocytes, and there is no current
therapy to reverse this process to improve long-term cardiac function. Due to a change in …

Heart disease is the principal cause of death in humans. Stem cell-based therapy for heart
regeneration has long been seen as a potential application since the heart lacks adequate …

Although significant advances have been made in terms of pharmacological, catheter‐
based, and surgical palliation, heart failure remains a fatal disease. As a curative concept …

Stem cell-based therapy is emerging as a promising strategy to treat end-stage heart failure,
a leading cause of morbidity and mortality. Stem cells can be isolated from a variety of …